Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pleural Effusion, Malignant × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 267 Carcinoma, Non-Small-Cell Lung 204 Neoplasms 188 Prostatic Neoplasms 154 Neoplasm Metastasis 119 Multiple Myeloma 118 Lung Neoplasms 102 Melanoma 99 Colorectal Neoplasms 99 Leukemia, Myeloid, Acute 97 Lymphoma 82 Ovarian Neoplasms 76 Lymphoma, Non-Hodgkin 70 Leukemia, Lymphocytic, Chronic, B-Cell 68 Pancreatic Neoplasms 65 Squamous Cell Carcinoma of Head and Neck 62 Hematologic Neoplasms 59 Myelodysplastic Syndromes 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Glioblastoma 56 Triple Negative Breast Neoplasms 52 Parkinson Disease 4, Autosomal Dominant Lewy Body 52 Brain Neoplasms 52 Leukemia 50 Recurrence 49 Head and Neck Neoplasms 49 Lymphoma, Follicular 45 Carcinoma, Hepatocellular 45 Colonic Neoplasms 43 Urinary Bladder Neoplasms 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02649894 2025-12-11

SWIFT

C. R. Bard

Phase NA Completed

119 enrolled 16 charts

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡